COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas, announced today that C. Randal Mills, Ph.D., President and CEO, is scheduled to present at the ThinkEquity Partners’ Fifth Annual Growth Conference in San Francisco on Monday, September 17, 2007 at 1:30 pm PDT (4:30 EDT).
